Blue Hole New Consumer Report, August 25 news, according to foreign news reports, Renault USA announced today that it has submitted a PMTA application to the FDA for VELO soluble nicotine lozenges, in order to apply after the deadline for PMTA on September 9, 2020. Continue to put on the market.

VELO lozenges will be reintroduced under the VELO brand by RJ Reynolds Vapor Company, a subsidiary of Reynolds in 2020.

VELO lozenges are designed to provide adult tobacco consumers with innovative alternatives to traditional combustible smokeless tobacco products. VELO’s soluble oral nicotine lozenges are available in hard and soft forms, as well as four flavor variants, including dark mint, mint, berry and crema.

VELO lozenges are made using tobacco-derived nicotine.

Although the application documents contain confidential business information, broadly speaking, the PMTA of VELO lozenges highlights key evidence that continues to sell these products is suitable for protecting public health. These applications include a series of scientific studies using established methods to compare and evaluate tobacco products and related health risks, including product analysis, information about human health risks, and evaluations showing the impact of VELO lozenges on the health of the entire population , Including users and non-users of tobacco products.

Dr. James Figlar, Executive Vice President and Head of Scientific and Regulatory Affairs of Reynolds, stated that VELO is an award-winning brand that brings continuous innovation to adult tobacco users. Submitting PMTA will help ensure adult tobacco consumption FDA-regulated, consumer-acceptable combustible tobacco substitute products. As we have pointed out in the past, we hope that as our PMTA team moves forward, the FDA will continue to take enforcement measures against illegally sold tobacco products introduced after August 8, 2016.

This is Renault's application following the Vuse Vibe, Ciro and Solo electronic nicotine delivery device applications.